Restoration of T-cell function in nude mice by grafting the epitheliomesenchymal thymic rudiment from 10-day-old euthymic embryos.

Cell Differ Dev

Institut d'Embryologie Cellulaire et Moléculaire du CNRS et du Collège de France, Nogent-sur-Marne.

Published: May 1989

The capacity of the uncolonized thymic epithelium to restore immune function in nude mice was demonstrated by grafting the 3rd branchial arch area taken from euthymic 10-day BALB/c embryos into syngeneic newborn nude mice. Twenty-six percent of the operated animals became immunocompetent. T-cell function was tested with skin grafts and the presence of high levels of Thy-1 positive cells plus a variety of in vitro culture assays: Con A stimulation of T lymphocytes, cytotoxicity and alloreactivity in MLR of the recipient toward allogeneic spleen cells. All these tests showed a pattern of response similar to normal euthymic BALB/c mice.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0922-3371(89)90752-1DOI Listing

Publication Analysis

Top Keywords

nude mice
12
t-cell function
8
function nude
8
restoration t-cell
4
mice
4
mice grafting
4
grafting epitheliomesenchymal
4
epitheliomesenchymal thymic
4
thymic rudiment
4
rudiment 10-day-old
4

Similar Publications

VPS45 Contributes to the Progression of Hepatocellular Carcinoma by Triggering the Wnt/β-Catenin Signaling Pathway.

Mol Carcinog

January 2025

Department of Gastroenterology, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.

Vacuolar protein sorting 45 (VPS45) has recently been implicated in the development of ovarian cancer and non-small cell lung cancer. However, its role in the onset and progression of hepatocellular carcinoma (HCC) remains unclear. This study aims to elucidate the function of VPS45 in HCC.

View Article and Find Full Text PDF

NKX6.3 modulation of mitotic dynamics and genomic stability in gastric carcinogenesis.

Cell Commun Signal

January 2025

Department of Pathology, Functional RNomics Research Center, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 06591, South Korea.

Background: Gastric cancer remains a significant global health challenge, characterized by poor prognosis and high mortality rates. Mitotic integrity and genomic stability are crucial in maintaining cellular homeostasis and preventing tumorigenesis. The transcription factor NKX6.

View Article and Find Full Text PDF

BRAT1 - a new therapeutic target for glioblastoma.

Cell Mol Life Sci

January 2025

Experimental Neurosurgery, Department of Neurosurgery, Neuroscience Center, Goethe University Hospital, Goethe University Frankfurt, 60528, Frankfurt am Main, Germany.

Glioblastoma (GBM), the most malignant primary brain tumor in adults, has poor prognosis irrespective of therapeutic advances due to its radio-resistance and infiltrative growth into brain tissue. The present study assessed functions and putative druggability of BRCA1-associated ATM activator 1 (BRAT1) as a crucial factor driving key aspects of GBM, including enhanced DNA damage response and tumor migration. By a stable depletion of BRAT1 in GBM and glioma stem-like (GSC) cell lines, we observed a delay in DNA double-strand break repair and increased sensitivity to radiation treatment, corroborated by in vitro and in vivo studies demonstrating impaired tumor growth and invasion.

View Article and Find Full Text PDF

S-palmitoylation is a reversible and widespread post-translational modification, but its role in the regulation of ferroptosis has been poorly understood. Here, we elucidate that GPX4, an essential regulator of ferroptosis, is reversibly palmitoylated on cysteine 66. The acyltransferase ZDHHC20 palmitoylates GPX4 and increases its protein stability.

View Article and Find Full Text PDF

Targeting estrogen-regulated system x promotes ferroptosis and endocrine sensitivity of ER+ breast cancer.

Cell Death Dis

January 2025

Wenzhou Key Laboratory of Cancer Pathogenesis and Translation, Key Laboratory of Laboratory Medicine, School of Laboratory Medicine and Life Sciences, Ministry of Education, Wenzhou Medical University, 325035, Wenzhou, China.

Estrogen receptor positive (ER+) breast cancer accounts for approximately 70% of cases. Endocrine therapies targeting estrogen are the first line therapies for ER+ breast cancer. However, resistance to these therapies occurs in about half of patients, leading to decreased survival rates.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!